SynthesisAnnals of medicine2025
From mechanisms to therapeutics: a narrative review on pyroptosis and autophagy in osteoporosis.
Synthesis in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Mechanisms and Therapeutic Potential of Puerariae Lobatae Radix in Bone Metabolism: A Comprehensive Review.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoporosis (OP) is a globally prevalent metabolic bone disorder, particularly affecting aging populations, and is characterized by an imbalance between bone resorption and formation. The pathogenesis of OP involves a complex interplay of genetic predisposition, hormonal changes, and chronic inflammatory pathways. Emerging evidence now indicates that pyroptosis, an inflammasome-mediated form of programmed cell death, and autophagy, a conserved intracellular catabolic process, are critical regulators of osteocyte viability and bone metabolism homeostasis.
methodsA systematic literature search was performed using PubMed and Web of Science for studies published from 2010 to 2024, with a focus on recent evidence (2020-2024). Seminal earlier publications were also considered. Inclusion criteria covered studies addressing both osteoporosis and pyroptosis/autophagy, their interaction, or related interventional strategies. Exclusions comprised articles not involving these mechanisms or lacking mechanistic insight into bone metabolism. Priority was given to experimental and clinical studies. Literature screening adhered to these criteria through title/abstract and full-text review.
resultsThe analysis confirmed that pyroptosis accelerated bone loss by activating inflammatory cascades, while autophagy exerted cytoprotective effects to maintain bone integrity. A dynamic interaction existed between these processes within osteocytes, forming a critical regulatory axis. Furthermore, specific natural compounds demonstrated the ability to modulate bone metabolism by targeting this axis, thereby offering novel mechanistic insights and promising therapeutic strategies for OP.
conclusionsPyroptosis-autophagy crosstalk represents a pivotal therapeutic target for osteoporosis. Future research should focus on developing dual-target therapies and conducting
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.